4 h after administration of… | ||||||
---|---|---|---|---|---|---|
ROI | Baseline (n = 15) | 100 μg (n = 1) | 50 μg (n = 3) | 25 μg (n = 2) | 10 μg (n = 3) | 24 h after administration of 25 μg (n = 6) |
Caudate | 69.9 ± 26.9* | 15.0 | 15.8 ± 3.2 | 16.1 | 24.8 ± 4.2 | 30.7 ± 18.7* |
Putamen | 95.2 ± 7.8 | 17.3 | 22.2* | 25.7 | 31.5 ± 5.3 | 44.6 ± 18.5 |
Cerebellum | 22.2 ± 3.5 | 8.50 | 10.5 ± 0.8 | 10.5 | 14.2 ± 1.8 | 14.5 ± 2.5 |
Frontal cortex | 28.4 ± 4.2 | 9.95 | 12.3 ± 0.9 | 12.1 | 16.2 ± 2.9 | 17.9 ± 3.5 |
Parietal cortex | 24.2 ± 3.7 | 9.53 | 11.6 ± 0.5 | 10.8 | 14.6 ± 2.3 | 16.3 ± 3.2 |
Occipital cortex | 21.8 ± 3.2 | 9.12 | 11.4 ± 0.8 | 10.5 | 13.5 ± 1.7 | 15.4 ± 2.2 |
Insula cortex | 38.7 ± 7.1 | 12.6 | 14.8 ± 1.4 | 16 | 19.2 ± 3.1 | 23.5 ± 4.0 |
Anterior cingulate cortex | 44.8 ± 14.6 | 12.6 | 14.5 ± 1.4 | 16.4 | 21.0 ± 4.0 | 23.3 ± 4.6 |
Hippocampus | 22.8 ± 3.6 | 9.25 | 10.1 ± 0.8 | 10 | 13.4 ± 1.5 | 15.0 ± 2.7 |
Amygdala | 36.5 ± 10.6 | 10.9 | 12.1 ± 0.5 | 14.9 | 17.5 ± 3.9 | 20.6 ± 5.3 |
Thalamus | 23.5 ± 3.4 | 10.7 | 11.2 ± 0.9 | 10.7 | 15.0 ± 2.2 | 16.5 ± 3.7 |
↵* Caudate or putamen could not be fitted for 1 subject.